- 全部删除
您的购物车当前为空
ZDLD20 是一种具有口服活性和选择性的CDK4抑制剂,是一种 β-咔啉类化合物,具有抗 HCT116 和抗癌活性,抑制集落形成、抑制侵袭和迁移、诱导细胞凋亡和阻止细胞周期的 G1 期。


为众多的药物研发团队赋能,
让新药发现更简单!
ZDLD20 是一种具有口服活性和选择性的CDK4抑制剂,是一种 β-咔啉类化合物,具有抗 HCT116 和抗癌活性,抑制集落形成、抑制侵袭和迁移、诱导细胞凋亡和阻止细胞周期的 G1 期。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 477 | In stock | |
| 5 mg | ¥ 1,160 | In stock | |
| 10 mg | ¥ 1,860 | In stock | |
| 25 mg | ¥ 3,730 | In stock | |
| 50 mg | ¥ 5,320 | In stock | |
| 100 mg | ¥ 7,280 | In stock | |
| 200 mg | ¥ 9,790 | In stock |
ZDLD20 相关产品
| 产品描述 | ZDLD20 is an orally active and selective CDK4 inhibitor, a β-carboline analog with anti-HCT116 and anticancer activity that inhibits colony formation, inhibits invasion and migration, induces apoptosis, and prevents the G1 phase of the cell cycle. |
| 靶点活性 | CDK4-CyclinD3:6.51 μM |
| 分子量 | 386.45 |
| 分子式 | C22H22N6O |
| CAS No. | 2762279-02-5 |
| Smiles | O=C(NC1=NC=C(C=C1)N2CCN(C)CC2)C3=NC=CC=4C=5C=CC=CC5NC34 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 15 mg/mL (38.81 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
评论内容